NCT03359356: A trial that was reported late by Icahn School of Medicine at Mount Sinai
This trial has reported, although it was 215 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03359356 |
|---|---|
| Title | Defining Reversal of Alopecia Areata (AA) Phenotype With Dupilumab in Patients With and Without Associated Atopic Dermatitis (AD) |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 9, 2018 |
| Completion date | Jan. 14, 2020 |
| Required reporting date | Jan. 13, 2021, midnight |
| Actual reporting date | Aug. 17, 2021 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 215 |